The health activists argue that the government is empowered with effective law and policy tools and therefore should ...

Health activists demand government action to reduce the cost of SMA medicines, citing constitutional obligations and ...

Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...

A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

A registry for rare disease patients in the state will become a reality this year, State Health Minister Veena George said on ...

Alterity Therapeutics Ltd. ( ($AU:ATH) ) just unveiled an update. Alterity Therapeutics has completed its Phase 2 clinical trial of ATH434 in ...

The Executive Director of the American Heart Association Chicago spoke about risk factors for new and expectant mothers when it comes to heart disease after she caught a life-threatening ...

Kochi: The central govt has informed the Kerala high court that there are more than 3,000 registered Group III rare diseases patients across 12 centre.

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...

As part of our Masterclass series, GP specialist in diabetes Dr Elizabeth Martin explains the key points in prevention, diagnosis and management of diabetes in general practice. This series showcases ...

Spinraza remains a big product for Biogen, but has seen its sales go into reverse as competition in SMA treatment has emerged ...